Radiotherapy/Radiation / TumCCA Cancer Research Results

Rad, Radiotherapy/Radiation: Click to Expand ⟱
Features:
Treatment of disease with radiation, especially by selective irradiation with x-rays or other ionizing radiation and by ingestion of radioisotopes.

Radiosensitizer
Atorvaqone, (mitochondria inhibitor) decrease O2 consumption making more O2 available as a radiosensitizer.


TumCCA, Tumor cell cycle arrest: Click to Expand ⟱
Source:
Type:
Tumor cell cycle arrest refers to the process by which cancer cells stop progressing through the cell cycle, which is the series of phases that a cell goes through to divide and replicate. This arrest can occur at various checkpoints in the cell cycle, including the G1, S, G2, and M phases. S, G1, G2, and M are the four phases of mitosis.


Scientific Papers found: Click to Expand⟱
4563- AgNPs,  Rad,    Silver nanoparticles enhance neutron radiation sensitivity in cancer cells: An in vitro study
- in-vitro, BC, MCF-7 - in-vitro, Ovarian, SKOV3 - in-vitro, GBM, U87MG - in-vitro, Melanoma, A431
RadioS↑, ROS↑, TumCCA↑, Apoptosis↑, ER Stress↑,
298- ALA,  Rad,    Synergistic Tumoricidal Effects of Alpha-Lipoic Acid and Radiotherapy on Human Breast Cancer Cells via HMGB1
- in-vitro, BC, MDA-MB-231
Apoptosis↑, P53↑, p38↑, NF-kB↑, TumCCA↑,
2289- Ba,  Rad,    Baicalein Inhibits the Progression and Promotes Radiosensitivity of Esophageal Squamous Cell Carcinoma by Targeting HIF-1A
- in-vitro, ESCC, KYSE150
TumCP↓, TumCMig↓, Glycolysis↓, cycD1/CCND1↓, CDK4↓, ECAR↓, TumCCA↑, HK1↓, ALDH↓, ALDOA↓, PKM2↓, Hif1a↓,
1399- BBR,  Rad,    Radiotherapy Enhancing and Radioprotective Properties of Berberine: A Systematic Review
- Review, NA, NA
*ROS↓, *MDA↓, *TNF-α↓, *TGF-β↓, *IL10↑, ROS↑, DNAdam↑, mtDam↑, MMP↓, Apoptosis↑, TumCCA↑, Hif1a↓, VEGF↓, RadioS↑,
5749- CA,  Z,  Rad,    Antitumor and Radiosensitizing Effects of Zinc Oxide-Caffeic Acid Nanoparticles against Solid Ehrlich Carcinoma in Female Mice
- vitro+vivo, BC, MCF-7 - NA, Liver, HepG2
RadioS↑, TumVol↓, Bcl-2↓, NF-kB↓, VCAM-1↓, ERK↓, DNAdam↑, TumCCA↑,
1870- DCA,  Rad,    Dichloroacetate (DCA) sensitizes both wild-type and over expressing Bcl-2 prostate cancer cells in vitro to radiation
- in-vitro, Pca, PC3
TumCCA↑, Apoptosis↑, MMP↓, eff↑, RadioS↑,
1620- EA,  Rad,    Radiosensitizing effect of ellagic acid on growth of Hepatocellular carcinoma cells: an in vitro study
- in-vitro, Liver, HepG2
ROS↑, P53↑, TumCCA↑, IL6↓, COX2↓, TNF-α↓, MMP↓, angioG↓, MMP9↓, BAX↑, Casp3↑, Apoptosis↑, RadioS↑, TBARS↑, GSH↓, Bax:Bcl2↑, p‑NF-kB↓, p‑STAT3↓,
3526- GoldNP,  Rad,    Advances in nanoparticle-based radiotherapy for cancer treatment
- Review, Var, NA
RadioS↑, EPR↑, ROS↑, TumCCA↑,
5038- SAS,  Rad,    Sulfasalazine, an inhibitor of the cystine-glutamate antiporter, reduces DNA damage repair and enhances radiosensitivity in murine B16F10 melanoma
- in-vivo, Melanoma, B16-F10
xCT↓, ROS↑, RadioS↓, GSH↓, selectivity↑, DNArepair↓, TumCCA↑, H2O2↑, Dose↝,
3297- SIL,  Rad,    Studies on radiation sensitization efficacy by silymarin in colon carcinoma cells
- in-vitro, CRC, HCT15 - in-vitro, CRC, RKO
TumCP↓, RadioS↑, TumCCA↑, DNAdam↓, MMP↓, ROS↓, *radioP↑,
4739- SSE,  Chemo,  Rad,    Therapeutic Benefits of Selenium in Hematological Malignancies
- Review, Var, NA
ChemoSen↑, radioP↑, QoL↑, Risk↓, *selenoP↑, TumCP↓, Inflam↓, ChemoSen↑, TumCCA↑, Apoptosis↑, angioG↓, Dose⇅, ROS↑, eff↑, Risk↓, eff∅, CSCs↓, ROS↑,

Showing Research Papers: 1 to 11 of 11

* indicates research on normal cells as opposed to diseased cells
Total Research Paper Matches: 11

Pathway results for Effect on Cancer / Diseased Cells:


Redox & Oxidative Stress

GSH↓, 2,   H2O2↑, 1,   HK1↓, 1,   ROS↓, 1,   ROS↑, 7,   TBARS↑, 1,   xCT↓, 1,  

Mitochondria & Bioenergetics

MMP↓, 4,   mtDam↑, 1,  

Core Metabolism/Glycolysis

ALDOA↓, 1,   ECAR↓, 1,   Glycolysis↓, 1,   PKM2↓, 1,  

Cell Death

Apoptosis↑, 6,   BAX↑, 1,   Bax:Bcl2↑, 1,   Bcl-2↓, 1,   Casp3↑, 1,   p38↑, 1,  

Protein Folding & ER Stress

ER Stress↑, 1,  

DNA Damage & Repair

DNAdam↓, 1,   DNAdam↑, 2,   DNArepair↓, 1,   P53↑, 2,  

Cell Cycle & Senescence

CDK4↓, 1,   cycD1/CCND1↓, 1,   TumCCA↑, 11,  

Proliferation, Differentiation & Cell State

ALDH↓, 1,   CSCs↓, 1,   ERK↓, 1,   p‑STAT3↓, 1,  

Migration

MMP9↓, 1,   TumCMig↓, 1,   TumCP↓, 3,   VCAM-1↓, 1,  

Angiogenesis & Vasculature

angioG↓, 2,   EPR↑, 1,   Hif1a↓, 2,   VEGF↓, 1,  

Immune & Inflammatory Signaling

COX2↓, 1,   IL6↓, 1,   Inflam↓, 1,   NF-kB↓, 1,   NF-kB↑, 1,   p‑NF-kB↓, 1,   TNF-α↓, 1,  

Drug Metabolism & Resistance

ChemoSen↑, 2,   Dose⇅, 1,   Dose↝, 1,   eff↑, 2,   eff∅, 1,   RadioS↓, 1,   RadioS↑, 7,   selectivity↑, 1,  

Clinical Biomarkers

IL6↓, 1,  

Functional Outcomes

QoL↑, 1,   radioP↑, 1,   Risk↓, 2,   TumVol↓, 1,  
Total Targets: 59

Pathway results for Effect on Normal Cells:


Redox & Oxidative Stress

MDA↓, 1,   ROS↓, 1,   selenoP↑, 1,  

Migration

TGF-β↓, 1,  

Immune & Inflammatory Signaling

IL10↑, 1,   TNF-α↓, 1,  

Functional Outcomes

radioP↑, 1,  
Total Targets: 7

Scientific Paper Hit Count for: TumCCA, Tumor cell cycle arrest
11 Radiotherapy/Radiation
1 Silver-NanoParticles
1 Alpha-Lipoic-Acid
1 Baicalein
1 Berberine
1 Caffeic acid
1 Zinc
1 Dichloroacetate
1 Ellagic acid
1 Gold NanoParticles
1 Sulfasalazine
1 Silymarin (Milk Thistle) silibinin
1 Selenite (Sodium)
1 Chemotherapy
Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include : 
  -low or high Dose
  -format for product, such as nano of lipid formations
  -different cell line effects
  -synergies with other products 
  -if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:%  IllCat:%  CanType:%  Cells:%  prod#:201  Target#:322  State#:%  Dir#:2
wNotes=0 sortOrder:rid,rpid

 

Home Page